NT5C2 R367Q
|
Leukemia
|
NT5C2 R367Q
|
Leukemia
|
mizoribine Sensitive: D – Preclinical
|
mizoribine Sensitive: D – Preclinical
|
NT5C2 R367Q
|
Leukemia
|
NT5C2 R367Q
|
Leukemia
|
DR6MP Resistant: D – Preclinical
|
DR6MP Resistant: D – Preclinical
|
NT5C2 R367Q
|
T Acute Lymphoblastic Leukemia
|
NT5C2 R367Q
|
T Acute Lymphoblastic Leukemia
|
mercaptopurine Resistant: D – Preclinical
|
mercaptopurine Resistant: D – Preclinical
|